3rik: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
m Protected "3rik" [edit=sysop:move=sysop]
No edit summary
Line 5: Line 5:
Authors: Orwig, S.D., Lieberman, R.L.
Authors: Orwig, S.D., Lieberman, R.L.


Description: THE ACID BETA-GLUCOSIDASE ACTIVE SITE EXHIBITS PLASTICITY IN BINDING 3,4,5,6-TETRAHYDROXYAZEPANE-BASED INHIBITORS: IMPLICATIONS FOR PHARMACOLOGICAL CHAPERONE DESIGN FOR GAUCHER DISEASE
Description: The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease

Revision as of 09:56, 27 April 2011

Unreleased structure

The entry 3rik is ON HOLD

Authors: Orwig, S.D., Lieberman, R.L.

Description: The acid beta-glucosidase active site exhibits plasticity in binding 3,4,5,6-tetrahydroxyazepane-based inhibitors: implications for pharmacological chaperone design for gaucher disease

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA